Cargando…

Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells

Cervical cancer is considered a common yet preventable cause of death in women. It has been estimated that about 420 women out of the 1400 women diagnosed with cervical cancer will die during 5 years from diagnosis. This review addresses the pathogenesis of cervical cancer in humans with a special e...

Descripción completa

Detalles Bibliográficos
Autor principal: Shehata, Marlene F
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1090600/
https://www.ncbi.nlm.nih.gov/pubmed/15857509
http://dx.doi.org/10.1186/1475-2867-5-10
_version_ 1782123898235518976
author Shehata, Marlene F
author_facet Shehata, Marlene F
author_sort Shehata, Marlene F
collection PubMed
description Cervical cancer is considered a common yet preventable cause of death in women. It has been estimated that about 420 women out of the 1400 women diagnosed with cervical cancer will die during 5 years from diagnosis. This review addresses the pathogenesis of cervical cancer in humans with a special emphasis on the human papilloma virus as a predominant cause of cervical cancer in humans. The current understanding of apoptosis and regulators of apoptosis as well as their implication in carcinogenesis will follow. A special focus will be given to the role of Rel/NF-κB family of genes in the growth and chemotherapeutic treatment of the malignant HeLa cervical cells emphasizing on Xrel3, a cRel homologue.
format Text
id pubmed-1090600
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-10906002005-05-07 Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells Shehata, Marlene F Cancer Cell Int Review Cervical cancer is considered a common yet preventable cause of death in women. It has been estimated that about 420 women out of the 1400 women diagnosed with cervical cancer will die during 5 years from diagnosis. This review addresses the pathogenesis of cervical cancer in humans with a special emphasis on the human papilloma virus as a predominant cause of cervical cancer in humans. The current understanding of apoptosis and regulators of apoptosis as well as their implication in carcinogenesis will follow. A special focus will be given to the role of Rel/NF-κB family of genes in the growth and chemotherapeutic treatment of the malignant HeLa cervical cells emphasizing on Xrel3, a cRel homologue. BioMed Central 2005-04-27 /pmc/articles/PMC1090600/ /pubmed/15857509 http://dx.doi.org/10.1186/1475-2867-5-10 Text en Copyright © 2005 Shehata; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Shehata, Marlene F
Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells
title Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells
title_full Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells
title_fullStr Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells
title_full_unstemmed Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells
title_short Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells
title_sort rel/nuclear factor-kappa b apoptosis pathways in human cervical cancer cells
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1090600/
https://www.ncbi.nlm.nih.gov/pubmed/15857509
http://dx.doi.org/10.1186/1475-2867-5-10
work_keys_str_mv AT shehatamarlenef relnuclearfactorkappabapoptosispathwaysinhumancervicalcancercells